Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine
    • Honors & Awards
    • Nursing
    • Quality and Safety
    • Careers
    • Giving
    • About DukeHealth.org
    • Contact Us

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > About Duke Medicine > Quality and Safety > Performance Measures > Heart Attack > Heart Attack Patients Given Fibrinolytic Medication within 30 Minutes of Arrival
Jumbo Large Regular Text:
Print
Quality and Safety
  • Patient Care Quality and Safety
  •   |   Performance Measures
  •   |   Safety and Quality Awards
  •   |   Improvement Initiatives
  •   |   Contact Us with Concerns

Heart Attack Patients Given Fibrinolytic Medication within 30 Minutes of Arrival

Share

Note: The chart on this page requires the Flash viewer. To see it, download and install the Flash plugin here:
Macromedia Flash Player

InstitutionRating
U.S. Average158%
N.C. Average240%
Top Hospitals3100%
Duke Raleigh Hospital5n/a
Duke University Hospital4n/a
Durham Regional Hospital5n/a

The rates displayed in this graph are for discharges April 2011 through March 2012. Source: hospitalcompare.hhs.gov
(1) The U.S. average includes all reporting hospitals in the United States.
(2) The N.C. average includes all reporting hospitals in the state of North Carolina.
(3) "Top Hospitals" represent the top 10% of hospitals nationwide. These hospitals achieved 100% on this measure.
(4) The number of cases is too small (less than 25) to reliably predict hospital performance.
(5) This hospital treated patients with this condition, but no patients met the CMS criteria for inclusion in the measure calculation.

What Does This Measure?

The percentage of eligible heart attack patients who received fibrinolytic drugs within 30 minutes of their arrival at the hospital.

Why Is This Important?

Heart attacks often occur when blood clots cause blockages in blood vessels, depriving the heart of sufficient oxygen. Fibrinolytic drugs help dissolve blood clots and improve blood flow to the heart. Doctors should only administer fibrinolytic drugs for certain patients.

What Are We Doing to Improve Our Performance?

Duke has enacted several initiatives to improve our performance. These include:

  • Computerized physician order entry (CPOE)
  • Electronic medical records (EMR)
  • Evidence-based medicine
  • HealthView patient portal
  • Heart attack-specific discharge instructions and patient education information
  • Nursing and physician education
  • Patient advocacy and support groups
  • Patient safety and clinical quality committees
  • Six Sigma
  • Standardized order sets

More Information

  • See more heart attack quality measures
  • See all performance measures
  • Compare Duke to other North Carolina hospitals at NC Hospital Quality Report
  • Compare Duke to regional and national hospitals at Hospital Quality Alliance's Hospital Compare
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Sept. 2, 2011
Published: Mar. 17, 2008
URL: http://www.dukehealth.org/about_duke/quality/performance_measures/heart_attack/fibrinolytic_drugs